Search liu.se

We reported a novel finding on the highly restricted and biased specificities of CLL Abs some years ago, showing limited target structures for the CLL Abs, which were exposed on oxidized-LDL, apoptotic cells...

The aim of our research is to elucidate how lysosomal functions are regulated in normal cells and how they are affected in different pathological conditions.

We are studying the pathogenesis of the disease in experimental systems using broad cell biological techniques. Special interest is devoted to psoriasin which is a small protein...

Our research program has been made possible by a generous donation from the Ingrid Asp Foundation. Our ultimate goal is to obtain an improved understanding of the pathogenesis of psoriasis and to find new modalities for its therapy.

We aim to study the signaling pathways involved in response/resistance to cisplatin, cetuximab, and radiotherapy in order to find new predictive markers and new targets for therapy

The ultimate goal of the research is to increase the understanding of the underlying mechanisms of skin diseases, in order to facilitate the development of more specific treatments and clinical care.

COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome. The results adds to our knowledge of the causes of the disease and prospects of reaching a diagnosis.

LiU has been awarded two EU-funded Marie Skłodowska-Curie Individual Fellowships for international postdocs. The projects will look at soft microrobots and how cancer spreads to the bones.

Wen Zhong, new DDLS Fellow at LiU, has been involved in a study connected to the Human Protein Atlas. The international collaborative study’s finding will contribute to identify novel therapeutic strategies of relevance for human brain disorders.

A study has followed individuals for more than 30 years after the onset of type 1 diabetes. The results show that the levels of long-term blood sugar can be used to accurately determine the risk of developing eye- and kidney complications.